Enliven Therapeutics
BiotechnologyBoulder, Colorado, United StatesPost-IPO Equity$920.0M total fundingwww.enliventherapeutics.com
Latest funding:$460.0M · Post-IPO Equity (June 11, 2026)
Angel investors who backed Enliven Therapeutics
27 investors in our database backed Enliven Therapeutics.
David Bonita
General Partner
Chau Khuong
Partner
Peter Thompson
Affiliate Professor, Neurosurgery
Scotland Stevens
General Partner
Rishi Gupta
Partner
Geoffrey Hsu
General Partner
Carter Neild
Managing Partner
Carl Gordon
Managing Partner
Erez Chimovits
Managing Director
Mona Ashiya
Private Equity Partner
Anat Naschitz
Managing Director
Nissim Darvish
Senior Managing Director
Jonathan Wang
Partner
Matthew Rizzo
Partner
Sven Borho
Managing Partner
Jonathan Silverstein
Managing Partner
Andy Schwab
Founder and Managing Partner
Scott Rocklage
Founding Partner
John Diekman
Founding Partner
Brian Daniels
Partner
Rebecca Chen
Research Associate
Deborah Palestrant
Partner, 5AM Ventures and Executive Chair, 4:59 Initiative
Kush Parmar, M.D., Ph.D.
Board Member
Paul Stone
Of Counsel
Mason Freeman
Professor of Medicine
Jonathan Weissman
Venture Partner
Vamsi Mootha
Venture Partner
Who invested in...
See every angel investor and VC behind well-known startups.
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Enliven Therapeutics.
Search investors